Promotion of tumor development in prostate cancer by progerin

Cancer Cell International

Volumn 10, Issue , 2010, Pages

  Tang, Yong ^a   Chen, Yakun ^a   Jiang, Hongmei ^a   Nie, Daotai ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; LAMIN A; MESSENGER RNA; PROGERIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL AGING; CELL STRAIN LNCAP; CELL STRAIN MCF 7; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 78549261763     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-10-47     Document Type: Article

References (27)

1. De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M, et al. Lamin a truncation in Hutchinson-Gilford progeria. Science 2003, 300(5628):2055. 10.1126/science.1084125, 12702809.
2. H G. Progeria: a form of senilism. Practitioner 1904, 73:188-217.
3. Hennekam RC. Hutchinson-Gilford progeria syndrome: review of the phenotype. Am J Med Genet A 2006, 140(23):2603-2624.
4. Pendas AM, Zhou Z, Cadinanos J, Freije JM, Wang J, Hultenby K, Astudillo A, Wernerson A, Rodriguez F, Tryggvason K, et al. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet 2002, 31(1):94-99.
5. Liu Y, Rusinol A, Sinensky M, Wang Y, Zou Y. DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A. J Cell Sci 2006, 119(Pt 22):4644-4649. 10.1242/jcs.03263, 17062639.
6. Varela I, Cadinanos J, Pendas AM, Gutierrez-Fernandez A, Folgueras AR, Sanchez LM, Zhou Z, Rodriguez FJ, Stewart CL, Vega JA, et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 2005, 437(7058):564-568. 10.1038/nature04019, 16079796.
7. Liu B, Wang J, Chan KM, Tjia WM, Deng W, Guan X, Huang JD, Li KM, Chau PY, Chen DJ, et al. Genomic instability in laminopathy-based premature aging. Nat Med 2005, 11(7):780-785. 10.1038/nm1266, 15980864.
8. Fishel R. Genomic instability, mutators, and the development of cancer: is there a role for p53?. J Natl Cancer Inst 1996, 88(22):1608-1609. 10.1093/jnci/88.22.1608, 8931599.
9. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998, 396(6712):643-649. 10.1038/25292, 9872311.
10. Scaffidi P, Misteli T. Lamin A-dependent nuclear defects in human aging. Science 2006, 312(5776):1059-1063. 10.1126/science.1127168, 1855250, 16645051.
11. Chen Y, Tang Y, Wang MT, Zeng S, Nie D. Human pregnane X receptor and resistance to chemotherapy in prostate cancer. Cancer Res 2007, 67(21):10361-10367. 10.1158/0008-5472.CAN-06-4758, 17974979.
12. Fischer AH, Taysavang P, Jhiang SM. Nuclear envelope irregularity is induced by RET/PTC during interphase. Am J Pathol 2003, 163(3):1091-1100. 1868259, 12937150.
13. Fischer AH, Taysavang P, Weber CJ, Wilson KL. Nuclear envelope organization in papillary thyroid carcinoma. Histol Histopathol 2001, 16(1):1-14.
14. Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB, Gruenbaum Y, Khuon S, Mendez M, Varga R, et al. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 2004, 101(24):8963-8968. 10.1073/pnas.0402943101, 428455, 15184648.
15. Scaffidi P, Misteli T. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med 2005, 11(4):440-445. 10.1038/nm1204, 1351119, 15750600.
16. Campisi J. Cancer, aging and cellular senescence. In Vivo 2000, 14(1):183-188.
17. Wang Y, Perrault AR, Iliakis G. Down-regulation of DNA replication in extracts of camptothecin-treated cells: activation of an S-phase checkpoint?. Cancer Res 1997, 57(9):1654-1659.
18. Kastan MB, Lim DS. The many substrates and functions of ATM. Nat Rev Mol Cell Biol 2000, 1(3):179-186. 10.1038/35043058, 11252893.
19. Moneef MA, Sherwood BT, Bowman KJ, Kockelbergh RC, Symonds RP, Steward WP, Mellon JK, Jones GD. Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivity. Br J Cancer 2003, 89(12):2271-2276. 10.1038/sj.bjc.6601333, 2395287, 14676805.
20. Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991, 51(12):3075-3079.
21. Aebi U, Cohn J, Buhle L, Gerace L. The nuclear lamina is a meshwork of intermediate-type filaments. nature 1986, 323:560-564. 10.1038/323560a0, 3762708.
22. Marino G, Ugalde AP, Salvador-Montoliu N, Varela I, Quiros PM, Cadinanos J, van der Pluijm I, Freije JM, Lopez-Otin C. Premature aging in mice activates a systemic metabolic response involving autophagy induction. Hum Mol Genet 2008, 17(14):2196-2211. 10.1093/hmg/ddn120, 18443001.
23. Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, Chen G, Jin S, White E. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 2007, 21(11):1367-1381. 10.1101/gad.1545107, 1877749, 17510285.
24. Young SG, Fong LG, Michaelis S. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria--new evidence suggesting that protein farnesylation could be important for disease pathogenesis. J Lipid Res 2005, 46(12):2531-2558. 10.1194/jlr.R500011-JLR200, 16207929.
25. Capell BC, Erdos MR, Madigan JP, Fiordalisi JJ, Varga R, Conneely KN, Gordon LB, Der CJ, Cox AD, Collins FS. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 2005, 102(36):12879-12884. 10.1073/pnas.0506001102, 1200293, 16129833.
26. End DW, Smets G, Todd AV, Applegate TL, Fuery CJ, Angibaud P, Venet M, Sanz G, Poignet H, Skrzat S, et al. Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro. Cancer Res 2001, 61(1):131-137.
27. Sepp-Lorenzino L, Ma Z, Rands E, Kohl NE, Gibbs JB, Oliff A, Rosen N. A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines. Cancer Res 1995, 55(22):5302-5309.